These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 15061266)
1. Optimized procedure of real-time systemic leakage monitoring during isolated limb perfusion using a hand held gamma probe and 99mTc-HSA. Casara D; Rubello D; Pilati P; Scalerta R; Foletto M; Rossi CR Nucl Med Commun; 2004 Jan; 25(1):61-6. PubMed ID: 15061266 [TBL] [Abstract][Full Text] [Related]
2. A simplified procedure for continuous intraoperative external monitoring of systemic leakage during isolated limb perfusion. Casara D; Rubello D; Pilati PL; Scalerta R; Foletto M; Rossi CR Tumori; 2002; 88(3):S61-3. PubMed ID: 12369560 [TBL] [Abstract][Full Text] [Related]
4. Radionuclide leakage monitoring during hyperthermic isolated limb perfusion for treatment of local melanoma metastasis in an extremity. Paulsen IF; Chakera AH; Schmidt G; Drejøe J; Klyver H; Oturai PS; Hesse B; Drzewiecki K; Mortensen J Clin Physiol Funct Imaging; 2015 Jul; 35(4):301-5. PubMed ID: 24902761 [TBL] [Abstract][Full Text] [Related]
5. Value of continuous leakage monitoring with radioactive iodine-131-labeled human serum albumin during hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan. van Ginkel RJ; Limburg PC; Piers DA; Koops HS; Hoekstra HJ Ann Surg Oncol; 2002 May; 9(4):355-63. PubMed ID: 11986187 [TBL] [Abstract][Full Text] [Related]
6. Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha. Laurenzi L; Natoli S; Di Filippo F; Calamaro A; Centulio F; Anzà M; Cavaliere F; Marcelli ME; Garinei R; Arcuri E J Exp Clin Cancer Res; 2004 Jun; 23(2):225-31. PubMed ID: 15354406 [TBL] [Abstract][Full Text] [Related]
7. Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: pharmacokinetic study and 99mTc-albumin microcolloid technique. Cattel L; Buffa E; De Simone M; Cesana P; Novello S; Dosio F; Ceruti M Anticancer Res; 2001; 21(3C):2243-8. PubMed ID: 11501854 [TBL] [Abstract][Full Text] [Related]
8. Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone. Vrouenraets BC; Eggermont AM; Hart AA; Klaase JM; van Geel AN; Nieweg OE; Kroon BB Eur J Surg Oncol; 2001 Jun; 27(4):390-5. PubMed ID: 11417986 [TBL] [Abstract][Full Text] [Related]
9. Systemic toxicity and cytokine/acute phase protein levels in patients after isolated limb perfusion with tumor necrosis factor-alpha complicated by high leakage. Stam TC; Swaak AJ; de Vries MR; ten Hagen TL; Eggermont AM Ann Surg Oncol; 2000 May; 7(4):268-75. PubMed ID: 10819366 [TBL] [Abstract][Full Text] [Related]
10. Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalan. Vrouenraets BC; Kroon BB; Ogilvie AC; van Geel AN; Nieweg OE; Swaak AJ; Eggermont AM Ann Surg Oncol; 1999 Jun; 6(4):405-12. PubMed ID: 10379864 [TBL] [Abstract][Full Text] [Related]
12. Monitoring system for isolated limb perfusion based on a portable gamma camera. Orero A; Vidal-Sicart S; Roé N; Muxí A; Rubí S; Duch J; Rull R; Pavón N; Pons F; Pavía J Nuklearmedizin; 2009; 48(4):166-72. PubMed ID: 19488461 [TBL] [Abstract][Full Text] [Related]
13. [Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs]. Abu-Abid S; Gutman M; Lev D; Inbar M; Chaitchik S; Sorkine P; Rudick V; Meller I; Klausner JM Harefuah; 1996 Oct; 131(7-8):227-32, 296, 295. PubMed ID: 8940515 [TBL] [Abstract][Full Text] [Related]
14. Systemic leakage and side effects of tumor necrosis factor alpha administered via isolated limb perfusion can be manipulated by flow rate adjustment. Sorkin P; Abu-Abid S; Lev D; Gutman M; Aderka D; Halpern P; Setton A; Kudlik N; Bar-On J; Rudich V Arch Surg; 1995 Oct; 130(10):1079-84. PubMed ID: 7575120 [TBL] [Abstract][Full Text] [Related]
15. Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs. Barker WC; Andrich MP; Alexander HR; Fraker DL Eur J Nucl Med; 1995 Nov; 22(11):1242-8. PubMed ID: 8575471 [TBL] [Abstract][Full Text] [Related]
16. Effects of isolated limb perfusion with tumor necrosis factor-alpha on circulating levels of proinflammatory cytokines. Ferroni P; Di Filippo F; Martini F; Spila A; D'Alessandro T; Cavaliere F; Anzà M; Garinei R; Aloe S; Carone MD; Gazzaniga PP; Guadagni F J Immunother; 2001; 24(4):354-62. PubMed ID: 11565837 [TBL] [Abstract][Full Text] [Related]
17. The use of a hand-held gamma detector improves the safety of isolated limb perfusion. Sardi A; Minton JP; Mojzisik C; Nieroda CA; Ferrara PJ; Hinkle GH; Thurston MO; Martin EW J Surg Oncol; 1989 Jul; 41(3):172-6. PubMed ID: 2664349 [TBL] [Abstract][Full Text] [Related]
18. Isolated limb perfusion: distinct tourniquet and tumor necrosis factor effects on the early hemodynamic response. Christoforidis D; Chassot PG; Mosimann F; Lienard D; Brunstein F; Bejko D; Lejeune FJ; Chiolero R Arch Surg; 2003 Jan; 138(1):17-25. PubMed ID: 12511144 [TBL] [Abstract][Full Text] [Related]
19. Continuous leakage measurement during hyperthermic isolated limb perfusion. Daryanani D; Komdeur R; Ter Veen J; Nijhuis PH; Piers DA; Hoekstra HJ Ann Surg Oncol; 2001 Aug; 8(7):566-72. PubMed ID: 11508617 [TBL] [Abstract][Full Text] [Related]
20. The use of isolated limb perfusion to manage recurrent malignant melanoma. Ma D; Ariyan S Clin Plast Surg; 2000 Jul; 27(3):441-50, ix. PubMed ID: 10941564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]